Home
>
National Drug Code (NDC)
>
PANCRELIPASE
PANCRELIPASE - 0179-0020-70 - (PANCRELIPASE)
Drug Information of PANCRELIPASE
| Product NDC: | 0179-0020 |
| Proprietary Name: | PANCRELIPASE |
| Non Proprietary Name: | PANCRELIPASE |
| Active Ingredient(s): | 56000; 20000; 44000 [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp; PANCRELIPASE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PANCRELIPASE
| Product NDC: | 0179-0020 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100201 |
Package Information of PANCRELIPASE
| Package NDC: | 0179-0020-70 |
| Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0020-70) |
NDC Information of PANCRELIPASE
| NDC Code | 0179-0020-70 |
| Proprietary Name | PANCRELIPASE |
| Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0020-70) |
| Product NDC | 0179-0020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PANCRELIPASE |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100201 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| Strength Number | 56000; 20000; 44000 |
| Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharmaceutical Classes |
